MedPath
HSA Approval

BEPROSALIC OINTMENT

SIN09029P

BEPROSALIC OINTMENT

BEPROSALIC OINTMENT

November 28, 1996

ZUELLIG PHARMA PTE. LTD.

ZUELLIG PHARMA PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantZUELLIG PHARMA PTE. LTD.
Licence HolderZUELLIG PHARMA PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

OINTMENT

TOPICAL

Medical Information

D07XC01

betamethasone

Manufacturer Information

ZUELLIG PHARMA PTE. LTD.

HOE PHARMACEUTICALS SDN BHD

Active Ingredients

BETAMETHASONE DIPROPIONATE 0.064% w/w EQV BETAMETHASONE

0.05% w/w

Betamethasone

SALICYLIC ACID

3%w/w

Salicylic acid

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

BEPROSALIC OINTMENT - HSA Approval | MedPath